Hedera Dx SA
Liquid biopsies for better therapy
Were united by a vision to make liquid biopsies globally accessible for patients. 1 in 3 people will be diagnosed with cancer during their lifetime. Hedera Dx was born to provide life-saving information for cancer patients when it matters most.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
27.05.2025
Hedera Dx raises €15M to bring modern cancer care to patients worldwide (startupticker.ch)
16.09.2024
Positive clinical progress in the biotech scene (startupticker.ch)
10.07.2024
Hedera Dx setzt neue Massstäbe in der Onkologie-Präzisionsmedizin (startupticker.ch)
17.10.2023
Hedera Dx Launches Blood Based Cancer Testing (startupticker.ch)
21.09.2022
€14 million to accelerate global adoption of liquid biopsies (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Hedera Dx SA
Liquid biopsies for better therapy
Website:
www.hederadx.com/
Headquarter:
Epalinges
Foundation Date:
July 2021
Technology:
- Biotech